AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cordish Dixon Private Equity Fund III

0.765

+0.0050.66%

Volume:72.99K

Turnover:55.44K

Market Cap:55.10M

PE:-6.11

High:0.765

Open:0.760

Low:0.755

Close:0.760

52wk High:0.986

52wk Low:0.735

Shares:72.03M

Float Shares:- -

Volume Ratio:3.76

T/O Rate:- -

Dividend:0.20

Dividend Rate:26.14%

EPS(TTM):-0.125

EPS(LYR):-0.125

ROE:-7.19%

ROA:-4.35%

PB:0.48

PE(LYR):-6.11

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Cd Pvt Equity Fund Iii-Net Tangible Asset Backing & Fund Update

THOMSON REUTERS

Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases

Cd Pvt Equity Fund Iii-Net Tangible Asset Backing & Fund Update

THOMSON REUTERS

If 24 LICs ran the Melbourne Cup, which ones would we back?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/CD3.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CD3.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CD3.AU\",,,,,undefined,":{"symbol":"CD3.AU","market":"AU","secType":"STK","nameCN":"Cordish Dixon Private Equity Fund III","latestPrice":0.765,"timestamp":1791522720000,"preClose":0.76,"halted":0,"volume":72986,"delay":0,"changeRate":0.006578947368421058,"nameEN":"Cordish Dixon Private Equity Fund III","floatShares":0,"shares":72028420,"eps":-0.1252,"marketStatus":"Market Closed","change":0.005,"latestTime":"10-09 16:12:00 AEDT","open":0.76,"high":0.765,"low":0.755,"amount":55444,"amplitude":0.013158,"askPrice":0.78,"askSize":25880,"bidPrice":0.76,"bidSize":7474,"shortable":3,"etf":0,"ttmEps":-0.1252,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791759600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.76,"dividendRate":0.261438,"openAndCloseTimeList":[[1791500400000,1791522000000]],"volumeRatio":3.7636005719517787,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CD3.AU","preClose":0.76,"auctionPrice":0.76,"auctionVolume":4603,"auction":3,"marketStatus":"盘后竞价","timestamp":1791522006607}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CD3.AU\",,,,,undefined,":{"symbol":"CD3.AU","floatShares":0,"roa":"-4.35%","roe":"-7.19%","lyrEps":-0.1252,"volumeRatio":3.7636005719517787,"shares":72028420,"dividePrice":0.2,"high":0.765,"amplitude":0.013158,"preClose":0.76,"low":0.755,"week52Low":0.735,"pbRate":"0.48","psRate":"-6.78","week52High":0.986,"institutionHeld":0,"latestPrice":0.765,"committee":-0.551838,"eps":-0.1252,"divideRate":0.261438,"volume":72986,"delay":0,"ttmEps":-0.1252,"open":0.76,"prevYearClose":0.935,"prevWeekClose":0.79,"prevMonthClose":0.745,"prevQuarterClose":0.745,"fiveDayClose":0.79,"twentyDayClose":0.83,"sixtyDayClose":0.787,"dividendPayoutRate":0.7763643633229949,"dividendGrowthYears":0,"dividendGrowthRate":-0.3,"fiveYearAvgDividendRate":0.45133197015038},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CD3.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-05","symbol":"CD3.AU","amount":0.12,"announcedDate":"2026-07-28","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-08-06","defaultRemindTime":1785888000000,"name":"Cordish Dixon Private Equity Fund III","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-27","payableDate":"2026-08-06","currency":"AUD","dateTimestamp":1785852000000,"payDate":"2026-08-27"},{"date":"2026-01-29","symbol":"CD3.AU","amount":0.04,"announcedDate":"2026-01-23","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-01-30","name":"Cordish Dixon Private Equity Fund III","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-24","payableDate":"2026-01-30","currency":"AUD","dateTimestamp":1769605200000,"payDate":"2026-02-24"},{"date":"2025-09-12","symbol":"CD3.AU","amount":0.1,"announcedDate":"2025-09-08","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-15","defaultRemindTime":1757635200000,"name":"Cordish Dixon Private Equity Fund III","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-08","payableDate":"2025-09-15","currency":"AUD","dateTimestamp":1757599200000,"payDate":"2025-10-08"},{"date":"2025-01-29","symbol":"CD3.AU","amount":0.13,"announcedDate":"2025-01-23","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-01-30","name":"Cordish Dixon Private Equity Fund III","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-02-24","payableDate":"2025-01-30","currency":"AUD","dateTimestamp":1738069200000,"payDate":"2025-02-24"},{"date":"2024-07-10","symbol":"CD3.AU","amount":0.07,"announcedDate":"2024-07-04","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-07-11","defaultRemindTime":1720569600000,"name":"Cordish Dixon Private Equity Fund III","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-05","payableDate":"2024-07-11","currency":"AUD","dateTimestamp":1720533600000,"payDate":"2024-08-05"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CD3.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2021-02-04","recordDate":"2021-02-05","paymentDate":"2021-02-19","value":0.24,"currency":"AUD"},{"executeDate":"2021-06-17","recordDate":"2021-06-18","paymentDate":"2021-06-29","value":0.125,"currency":"AUD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2022-01-21","value":0.53,"currency":"AUD"},{"executeDate":"2022-06-29","recordDate":"2022-06-30","paymentDate":"2022-08-19","value":0.241,"currency":"AUD"},{"executeDate":"2022-11-03","recordDate":"2022-11-04","paymentDate":"2022-11-25","value":0.21,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CD3.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2619154407","title":"Cd Pvt Equity Fund Iii-Net Tangible Asset Backing & Fund Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2619154407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619154407?lang=en_us&edition=fundamental","pubTime":"2026-03-13 11:27","pubTimestamp":1773372452,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nTUE1DPZLD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CD3.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616377532","title":"Antengene and UCB Enter Global License Agreement for ATG-201, a CD19/CD3 Bispecific T-Cell Engager for Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2616377532","media":"prnewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616377532?lang=en_us&edition=fundamental","pubTime":"2026-03-04 06:00","pubTimestamp":1772575200,"startTime":"0","endTime":"0","summary":"Antengene grants UCB worldwide exclusive rights to develop, manufacture and commercialize ATG-201, a CD19/CD3 bispecific T-cell engager  antibody, targeting B cell-related autoimmune diseases.Antengene will receive USD 80 million of upfront and near-term milestone payments, and is eligible to receive more than USD 1.1 billion in success-based development, regulatory and sales milestones, along with tiered royalties on future net sales.Deal underscores AnTenGager platform's unique capabilities in developing next-generation novel TCEs with broad applicability. Following this collaboration, 9 disclosed products remain in the R&D pipeline under the AnTenGager platform.Antengene to host conference call and webcast at 9:00 a.m. HKT  and 10:00 p.m. HKT  on Wednesday, March 4, 2026.Antengene's AnTenGager platform offers a differentiated T-cell engager ap","market":"nz","thumbnail":"https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/antengene-and-ucb-enter-global-license-agreement-for-atg-201-a-cd19cd3-bispecific-t-cell-engager-for-autoimmune-diseases-302702650.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","BK7095","CRS.AU","IE00B19Z4B17.USD","CD3.AU","IE00B66KJ199.SGD","BK4187","UCB","LU2065731478.USD","LU0963586101.USD","BK4211","IE00B7SZL793.SGD","BK4006","CRS","USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2590252802","title":"Cd Pvt Equity Fund Iii-Net Tangible Asset Backing & Fund Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2590252802","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590252802?lang=en_us&edition=fundamental","pubTime":"2025-12-12 09:09","pubTimestamp":1765501763,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nTUEBGVFSW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CD3.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580244909","title":"If 24 LICs ran the Melbourne Cup, which ones would we back?","url":"https://stock-news.laohu8.com/highlight/detail?id=2580244909","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580244909?lang=en_us&edition=fundamental","pubTime":"2025-11-04 04:00","pubTimestamp":1762200019,"startTime":"0","endTime":"0","summary":"How time flies. Welcome to the ninth running of the Affluence LIC Melbourne Cup!We do this analysis every day, but it’s that special first Tuesday of November when we publish our form guide for all to see.As a reminder or introduction to new readers of our guide, to win the real Melbourne Cup requires a horse that is well-trained, has a great jockey, and hasn’t been hit too hard with a weight handicap from the stewards.To win the Affluence LIC Cup, an LIC requires many of the same attributes. They require a great trainer , an opportunistic jockey , and a favourable handicap . Get all that right, and a good result for the owners  will surely not be too far away.There is over $55 billion of gamblers'  money at stake in the Listed Investment Company sector, which makes it significantly bigger than the Melbourne Cup.Lion Selection Group .We called it, and LSX bolted.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/if-24-lics-ran-the-melbourne-cup-which-ones-would-we-back","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/if-24-lics-ran-the-melbourne-cup-which-ones-would-we-back","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["PE1.AU","SDR.AU","CD2.AU","WMA.AU","CD3.AU","SNC.AU","PMC.AU","WAR.AU","CD1.AU","PIA.AU","MXT.AU","AFI.AU","MRE.AU","LSX.AU","SB2.AU","NAC.AU","TVL.AU","ACQ.AU","BK7062","TEK.AU","BTI.AU","PGF.AU","LRT.AU","MFF.AU","BK7016","MIR.AU","RF1.AU","RYD.AU","GVF.AU","NCC.AU","NSC.AU","TOP.AU","NGE.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CD3.AU\",params:#limit:6,delay:true,,,undefined,":[]}}